Schedule 13G ownership disclosure

PELTHOS THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 171126204

Event date: 2025-07-01

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • 3i, LP

    Shares: 303,138.00 · Class: 9.9%

  • 3i Management LLC

    Shares: 303,138.00 · Class: 9.9%

  • Maier Joshua Tarlow

    Shares: 303,138.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-25-001111
Form type
SCHEDULE 13G
Filer
3i, LP
CIK
CIK 1841619
Filed
Jul 08, 2025
Reporting period
Jul 01, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub